Abstract P-169

Y. Zhang,Xu Xi,Yun Cui,Weiyu Fei,Yan Ren,Chunxia Wu
DOI: https://doi.org/10.1097/01.pcc.0000537626.93411.4d
2018-01-01
Pediatric Critical Care Medicine
Abstract:Aims & Objectives: The aim of this study is to evaluate the effect of continuous hemofiltration in patients with sepsis-associated pediatric acute liver failure initially infected by bacteria (sepsis-associated PALF). Methods We retrospectively analyzed the medical records of 27 patients with sepsis-associated PALF admitted to pediatric intensive care unit (PICU) of Shanghai Children’s Hospital between January 2013 and December 2016. Results 28-day mortality and the length of stay in PICU of patients were significantly reduced in continuous hemofiltration group (n = 16) compared with the conventional management group (n = 11). The interval time between PICU admission and continuous hemofiltration initiation was 22.06 ± 17.68 hours, and the median time of continuous hemofiltration was 48 (31–70) hours. After 72h hemofiltration, the levels of total bilirubin (TBIL), direct bilirubin (DBIL), total bile acids (TBA), ammonia, lactate (Lac), TNF-α and IL-6 were significantly lower in continuous hemofiltration group compared with the conventional management group. Moreover, multivariate logistic regression analysis indicated that treatment with continuous hemofiltration and the level of TBIL were independent factors associated with prognosis of patients with sepsis-associated PALF. Conclusions Continuous hemofiltration significantly decreases the serum levels of TBIL, DBIL, TBA, Lac, ammonia, TNF-α, IL-6, and improves 28-day mortality of patients with sepsis-associated PALF.
What problem does this paper attempt to address?